Research output per year
Research output per year
Personal profile
Biography
I am Lecturer in Computer Science at the University of Roehampton, London, and honorary researcher at University College London (UCL). My vision is to examine systems related to natural life to elucidate its first principles and understand the emergent dynamics through the use of computational and biological models. I have a PhD in Modelling of Biological Complexity from UCL, 5 years postdoctoral experience at the Integrated Mathematical Oncology (IMO) department at H. Lee Moffitt Cancer Center, and 3 years experience in the AI industry. I model cancer at the interphase between computer science, biology and the clinic. I have been awarded for this research a fellowship usually reserved for experimental biologists from the Department of Defense of the United States, and the first Braintree Research Fellowship to develop novel AI techniques to tackle the disease. Through research, teaching and science outreach, my long-term goal is to contribute to the development of the fundamental laws of biology that will allow for the much needed exploration, understanding and optimal treatment of cancer.
Qualifications
2008-2013PhD - University College London (UCL), London, United Kingdom
2007-2008 MRes - UCL, London, United Kingdom
2007 Physics HS Teaching Programme - CERN, Geneva, Switzerland
2000-2006 BSc Physics 1st class hon- Universidad de las Américas, Puebla, Mexico
2004-2005 Academic exchange towards BSc - University of Notre Dame, Indiana, USA
2000-2006 Art Studio Cert - Universidad de las Américas, Puebla, Mexico
Research interests
Cancer, AI, Complex Systems and Art
Education/Academic qualification
Computer Science, PhD, Modelling Biological Complexity, University College London
22 Sept 2008 → 28 Oct 2013
Award Date: 28 Oct 2013
External positions
Honorary Researcher, University College London
22 May 2018 → …
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score
Schaefer, H., Rübben, A., Esser, A., Araujo, A., Persa, O-D., Leijs, M. & Burger, M. C. (ed.), 25 Aug 2022, (E-pub ahead of print) In: PLoS One. 17, 8, p. e0273478Research output: Contribution to journal › Article › peer-review
Open Access7 Downloads (Pure) -
Quantification and Optimization of Standard-of-Care Therapy to Delay the Emergence of Resistant Bone Metastatic Prostate Cancer
Araujo, A., Cook, L. M., Frieling, J. S., Tan, W., John A. Copland, II., Kohli, M., Gupta, S., Dhillon, J., Pow-Sang, J., Lynch, C. C. & Basanta, D., 8 Feb 2021, In: Cancers. 13, 4, 677.Research output: Contribution to journal › Article › peer-review
Open Access -
Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer
Warman, P. I., Kaznatcheev, A., Araujo, A., Lynch, C. C. & Basanta, D., 2 Mar 2018Research output: Other contribution › peer-review
-
Size Matters: Metastatic cluster size and stromal recruitment in the establishment of successful prostate cancer to bone metastases
Araujo, A., Cook, L. M., Lynch, C. C. & Basanta, D., 18 Dec 2017Research output: Other contribution › peer-review